FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula (I) which are protein tyrosine kinase 1B(PTP-1B) inhibitors and can be used in medicinal preparations for treating and preventing diseases related to high concentration of glucose in blood, for example diabetes and obesity. In formula (I) X is a X-1 group or X-2: , where R1 and R2 are each independently selected from a group consisting of hydrogen, lower alkyl, alkoxy-lower alkyl and hydroxyl-lower alkyl, under the condition that, R1 and R2 both represent hydrogen; R3, R4, R6 and R7 are each independently selected from a group consisting of hydrogen, lower alkyl; lower alkyl substituted with halogen or hydroxy; lower alkoxy; lower alkoxy substituted with halogen, hydroxy or lower alkoxy; hydroxyl, halogen, lower alkylthio, lower alkylsufanyl, lower alkylsufanyl, aminosufonyl, cyano, nitro, carbamoyl, lower mono- or dialkylcarbamoyl, lower alkanoyl, benzoyl, phenyl, phenyl substituted with halogen, phenyloxy, lower mono- or dialkylamino, hydroxy-substituted lower alkylamino, lower alkanoylamino, lower alkylsulfonylamino, heterocycloalkyl, hydroxy-substituted heterocycloalkyl, heterocyclyloxy, heterocyclylcarbonyl; where each heterocycloalkyl in the said values represents a 5-6-membr ring containing 1-2 heteroatoms selected from nitrogen and oxygen, and which can be substituted with lower alkyl or phenyl-lower alkyl; carboxyl, lower alkoxycarbonyl and a substitute of formula: ; R8 is selected from a group consisting of hydrogen, lower alkylthio, halogen, alkoxy-lower alkoxy, lower alkoxy, halogen-lower alkyl, hydroxy-lower alkyl; represents a 5-member heteroaromatic ring containing 1 or 2 heteroatoms selected from a group consisting of hydrogen, sulphur and nitrogen; R8 and R9 each independently represents hydrogen or lower alkyl.
EFFECT: novel compounds have useful biological properties.
31 cl, 7 dwg, 152 ex
Title | Year | Author | Number |
---|---|---|---|
DIAMINOPYRROLO QUINAZOLINES DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS | 2004 |
|
RU2345079C2 |
QUINAZOLINYLMETHYLENETRIAZOLINONES AS CDK-1 INHIBITORS | 2005 |
|
RU2405782C2 |
DIAMINOPYRROLOQUINAZOLINES DERIVATIVES AS PROTEINTYROSINE PHOSPHATASE INHIBITORS | 2004 |
|
RU2367664C2 |
COMT INHIBITORS | 2013 |
|
RU2642779C2 |
AMINOPYRIDINE DERIVATIVES AS MODULATORS OF LEUCINE-RICH REPEATED KINASE 2 (LRRK2) | 2012 |
|
RU2634716C2 |
2-PHENYLIMIDAZO[1,2-A]PYRIMIDINES AS IMAGING AGENTS | 2014 |
|
RU2665580C2 |
QUINAZOLINE DERIVATIVE AND PHARMACEUTICAL PREPARATION | 2006 |
|
RU2464263C2 |
CERTAIN CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2014 |
|
RU2718876C2 |
METHOD OF WOUND HEALING WITH APPLYING ANTAGONISTS OF A ADENOSINE RECEPTOR | 2005 |
|
RU2385322C2 |
AMINOPYRAZINE DERIVATIVES AND MEDICATIONS | 2010 |
|
RU2535217C2 |
Authors
Dates
2010-02-20—Published
2005-11-02—Filed